# Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

> **NCT02704052** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 116 (actual)

## Conditions studied

- Deep Venous Thrombosis
- Pulmonary Embolus
- Venous Thromboembolism

## Interventions

- **DRUG:** Real time enoxaparin dose adjustment
- **DRUG:** Standard enoxaparin dose

## Key facts

- **NCT ID:** NCT02704052
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-07
- **Final completion:** 2018-10
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704052, "Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02704052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*